What: 33 New York Ave. 

Where: Framingham 

Owner: King Street Properties 

Built: 1979 

Nasdaq-listed biotech company Replimune Group Inc. has leased 63,278 square feet at 33 New York Ave. in Framingham for a new office, lab and pharma manufacturing facility. 

Boston-based King Street Properties acquired the former MetroWest Daily News property in February for nearly $9.3 million and announced plans to build a 9,000-square-foot addition that expands the building to 107,350 square feet. 

Woburn-based cancer treatment researchers Replimune recently raised over $100 million in an initial public offering and sought a new facility for expansion. The company is scheduled to take occupancy of the new space in the third quarter of 2019. 

Newmark Knight Frank Executive Managing Directors Richard Ruggiero and Mark Winters represented Replimune in the lease transaction. Cushman & Wakefield’s Kevin Hanna and Paul Leone represented King Street Properties. 

They Said It: 

“33 New York Ave. was the perfect fit for our client, due to its centralized location, planned renovation, and ownership’s depth of life science experience.” — Richard Ruggiero, executive managing director, Newmark Knight Frank